Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | +2.26% | +5.65% | +68.63% |
06/05 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.63% | 11.95M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Transcript : Chemomab Therapeutics Ltd., Q1 2023 Earnings Call, May 11, 2023